Score history

Ameano Peptides score history

Every recorded change to Ameano Peptides’s overall score since July 23, 2026, with the audit note written at the time. Scores follow our published methodology; affiliate status never affects them.

Score today
7.80/10

Score today

Score changes
9

Score changes

Audit entries
10

Audit entries

Score over time

7.07.58.08.59.0Nov 20267.80
Overall score, October 21, 2026 to November 6, 2026. Each dot is a recorded score; the filled dot is today’s.

Every entry newest first

  1. Raised from7.70to7.80(+0.10)

    Ameano Peptides re-check of 2 November shipping and refunds 7.5 to 8.0.

  2. Lowered from7.75to7.70(-0.05)

    Claim deductions re-checked on 22 October 2026 under the published rule (only site claims contradicted by what the certificates show), each confirmed independently from primary sources. Lab 8.4 to 8.3. Note added 22 October 2026: a score on this entry was corrected from 7.69 to 7.70; it had been rounded down instead of half up.

  3. Raised from7.74to7.75(+0.01)

    Operating history re-checked on 22 October 2026 under the published rule (earliest dated evidence of the business, including a never-parked store domain and the named operating company, looked up for every vendor): operating history 2.6 to 2.9.

  4. Lowered from7.79to7.74(-0.05)

    Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: transparency 7.0 to 6.0.

  5. Lowered from8.66to7.79(-0.87)

    Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 10.0 to 7.5, pricing 9.5 to 7.9, operating history 2.8 to 2.6, transparency 9.5 to 7.0.

  6. Raised from7.83to8.66(+0.83)

    Janoshik certificates confirmed on 22 October 2026 at the laboratory's own verification site, so each confirmed report now earns the key-confirmed credit under our published lab rule. Lab 6.9 to 8.4.

  7. Raised from7.78to7.83(+0.05)

    Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for certificates more than 12 months old. Lab 6.8 to 6.9.

  8. Raised from7.29to7.78(+0.49)

    Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 28 of the 28 products we list that the vendor offers for sale. Lab 5.9 to 6.8.

  9. Lowered from8.04to7.29(-0.75)

    Lab 7 to 5.9 and tenure 5.9 to 2.8. Recomputed under our published rule, which averages the lab score over the products we list and counts a listed product with no certificate as zero: the certificate links for ARA-290 and AHK-Cu did not lead to certificates for those products and Bronchogen has none, and the Janoshik reports could not be checked at the laboratory. The domain was registered in January 2025, so the operating-history score was aligned to that date.

  10. Re-checked, no change

    Re-audited from live COAs. Verified 40 Janoshik reports (purity, identity, content). Noted no sterility or heavy-metals panels and generally over-label content.

Score changes for every vendor are on the score changes page. Ameano Peptides may display its current score with the score badge, which updates automatically and has no effect on the score.

Age verification

Are you 18 or older?

Peptide Source Review covers research peptides: substances sold for laboratory and research purposes, not for human consumption. By continuing, you confirm that you are at least 18 years old and that nothing on this site is medical or legal advice.

I am not 18, leave

We use a one-time browser memory (localStorage) so you don’t see this again on this device.